Interference, Opposition, Reexamination and Reissue. 7.3.1 Vertex shall, within ten (10) days of learning of such event, inform Merck of any request for, or filing or declaration of, any interference, opposition, or reexamination relating to Patent Rights. Merck and Vertex shall thereafter consult and cooperate fully to determine a course of action with respect to any such proceeding. Merck shall have the right to review and approve any submission to be made in connection with such proceeding.
Appears in 4 contracts
Samples: License and Commercialization Agreement (Vertex Pharmaceuticals Inc / Ma), Confidential Treatment Requested (Vertex Pharmaceuticals Inc / Ma), License and Commercialization Agreement (Vertex Pharmaceuticals Inc / Ma)
Interference, Opposition, Reexamination and Reissue. 7.3.1 Vertex (a) RENOVIS shall, within ten (10) days of learning of such event, inform Merck MERCK of any request for, or filing or declaration of, any interference, opposition, or reexamination relating to Patent Rights. Merck MERCK and Vertex RENOVIS shall thereafter consult and cooperate fully to determine a course of action with respect to any such proceeding. Merck MERCK shall have the right to review and approve any submission to be made in connection with such proceeding.
Appears in 2 contracts
Samples: Patent License and Research Collaboration Agreement (Renovis Inc), Patent License and Research Collaboration Agreement (Renovis Inc)
